Novartis, PTC Therapeutics and Huntington's disease

Research indicates β-blockers may reduce the risk of motor diagnosis and slow symptom progression in Huntington's disease, ...
The findings suggest that beta-blockers and other drugs that help restore balance to the autonomic nervous system may have ...
A patient in the UK has received a new therapy for Huntington’s disease, which experts hope could slow progression of the ...
Novartis is paying $1 billion upfront for global rights to PTC Therapeutics’ midphase Huntington's disease program, helping ...
The Wicked Witch of the West and I have something in common: We both use our fatal flaws to our advantage—for her, her green ...
Common symptoms of Huntington's include uncontrolled movements like jerking and twitching, loss of coordination, difficulty ...
After years of setbacks, biotechs are advancing treatments for Huntington’s disease, offering new hope as clinical studies ...
A common heart drug may slow the progression of Huntington's disease (HD), according to a new study by University of Iowa ...